David E. Lanfear MD MS
Heart Failure & Transplantation
Chief Scientific Officer, Henry Ford Health; Advanced Heart Failure and Transplant Cardilogist; Professor, WSU School of Medicine; Professor, MSU College of Human Medicine;
Join to View Full Profile
Henry Ford Health System2799 West Grand BoulevardDetroit, MI 48202
Phone+1 313-916-9106
Fax+1 313-916-1249
Dr. Lanfear is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Lanfear is a cardiologist in Detroit, MI and is affiliated with Henry Ford Hospital. He received his medical degree from University of Michigan Medical School and has been in practice 19 years. He specializes in heart failure & transplantation and is experienced in echocardiography, cardiac critical care, heart failure and transplantation, vad management, and pharmacogenetics.
Education & Training
University of Michigan School of Public HealthMS, Biostatistics and Research Design, 2005 - 2007
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2001 - 2005- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2001
University of Michigan Medical SchoolClass of 1998
Certifications & Licensure
MI State Medical License 2005 - 2027
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2013, 2015-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Centricity RIS-IC, GE Healthcare, 2013, 2015-2017
Clinical Trials
- INcrease Of VAgal TonE in CHF Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- The environmental exposome in heart failure risk and progression.Omar Hahad, Sojin Wass, Sanjay Rajagopalan, Shady Abohashem, Hua Hao
Nature Reviews. Cardiology. 2026-07-01 - Oxygen Transport Impairment in the Failing Heart: A Histology-Image-Based Computational Analysis.Haifeng Wang, Mythri Tumbalam Gooty, David E Lanfear, Hani N Sabbah, Lik-Chuan Lee
Annals of Biomedical Engineering. 2026-06-10 - Comparing Outcomes of a Rapid High-Sensitivity Troponin Protocol Between Hospital-Based and Freestanding Emergency Departments.Satheesh Gunaga, Joseph Miller, Bernard Cook, Chaun Gandolfo, Kegham Hawatian
Academic Emergency Medicine. 2026-03-01
Journal Articles
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, David E Lanfear, Thomas M Suter, Narimon Honarpour, Siddique A Abbasi, Fady I Malik, Christopher E Kurtz, The New England Journal of Medicine
- Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndromeDavid E Lanfear 1, Philip G Jones, Sharon Marsh, Sharon Cresci, Howard L McLeod, John A Spertus, JAMA, 9/28/2005
Authored Content
- Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
- Cardiopulmonary Exercise Measures of Men and Women with Hfref Differ in Their Relationship to Prognosis: The Henry Ford Hospital Cardiopulmonary Exercise Testing (Fit-CPX) ProjectFebruary 2018
Press Mentions
Put It on the BoardMay 18th, 2023- Illumina Taps Henry Ford Health System to Explore Whole-Genome Testing for Heart DiseaseApril 17th, 2023
- Illumina, Henry Ford Health Partner to Study Impact of CGP on Cardiovascular DiseaseApril 11th, 2023
Grant Support
- Development of Polygenic Scores for Medication Response in Diverse PopulationsHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES2024–2026
- Impact Of RACE And Genetic Factors On Beta-Blocker Effectiveness In Heart FailureNational Heart, Lung, And Blood Institute2011–2012
- Pharmacogenetics Of The B-Type Natriuretic Peptide PathwayNational Heart, Lung, And Blood Institute2008–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
